Despite a twofold increase in colorectal cancer screening among average-risk individuals aged 45 to 49 years after the 2021 recommendation, disparities in socioeconomic status and locality underscore the need for targeted interventions.

On September 20, 2024, the Federal Trade Commission sued the three largest pharmaceutical benefit managers (PBMs) – Caremark Rx, Express Scripts (ESI), and Optum Rx – alleging competition and consumer protection law violations.

National Hispanic Heritage Month (September 15-October 15) is a time to celebrate the rich culture and history of Hispanic Americans.

The Consumer Financial Protection Bureau (CFPB) on Tuesday issued a consumer advisory to combat families being targeted by “illegal medical debt collection tactics.”

Screening patients with cancer for financial toxicity is feasible, but experts say it should be thoughtfully integrated into oncology practice workflows with quality of life in mind and appropriate interventions in place.

Veracyte, Inc., a leading cancer diagnostics company, announced that new data from the multicenter, prospective VANDAAM trial show that the Decipher Prostate Genomic Classifier accurately predicts aggressive prostate cancer among African American men with early-stage disease.

Too many Americans know the pain of losing a mother, sister, wife, daughter, or loved one to breast cancer.

Despite the real mental and physical toll of developing cancer at younger ages, many patients find clarity through the process, experts say.

Across all kinds of cancer, Black Americans have higher rates of mortality and, often, more aggressive forms of the disease.

The cisplatin shortage that occurred resulted in the use of alternative therapies for the treatment of head and neck cancers, which led to significant cost increases for patients and payers, according to findings from a study presented at the 2024 ASCO Quality Care Symposium.